默克藥廠 MRK

-
-
-
已收盤:-

本益比明細

年季
收盤價
本業佔比%
本益比(近四季)
每股稅後盈餘(元)
營業利益(千)
稅後純益(百萬)
2025Q4 105.26 112.63 13.73 1.20 3,852,000 2,963
2025Q3 83.93 96.47 12.78 2.32 6,507,000 5,785
2025Q2 79.16 99.84 11.40 1.76 4,991,000 4,427
2025Q1 89.76 99.41 13.25 2.01 5,868,000 5,079
2024Q4 99.48 103.05 14.70 1.48 4,297,000 3,743
2024Q3 113.56 96.02 23.70 1.24 3,928,000 3,157
2024Q2 123.80 100.75 135.98 2.15 6,050,000 5,455
2024Q1 131.95 99.42 915.57 1.87 5,637,000 4,762
2023Q4 109.02 96.19 59.95 -0.48 -1,968,000 -1,226
2023Q3 102.95 102.30 83.97 1.86 5,749,000 4,745
2023Q2 115.39 96.81 94.12 -2.35 -5,165,000 -5,975
2023Q1 106.39 102.44 20.70 1.11 3,739,000 2,821
2022Q4 110.95 97.87 18.43 1.18 3,438,000 3,017
2022Q3 86.12 111.95 13.16 1.28 4,011,000 3,248
2022Q2 91.17 109.81 16.26 1.55 4,927,000 3,944
2022Q1 82.05 114.56 15.89 1.70 5,569,000 4,310
2021Q4 76.64 91.46 1.48 3,575,000 3,758
2021Q3 75.11 91.47 27.06 1.80 4,817,000 4,567
2021Q2 77.77 94.00 28.02 0.61 1,614,000 1,545
2021Q1 73.56 87.06 27.60 1.25 3,014,000 3,179